Skip to main content

Table 1 Patient and tumor characteristics

From: Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

Patient Pathological subtypes Subsites TNM Neck levels involved Nodal extracapsular spread Surgical margin status PTV 63 PTV 54
Volume (cm 3)/ Volume (cm 3)/
Height (cm) Height (cm)
1 Medullary Right lobe T3N1a R: VI Y R1 298.55/13.26 534.84/18.42
2 Medullary Left lobe T4aN1b R: VI Y R1 490.76/14.54 954.89/20.62
L: II, III, V, VI
3 Vesicular Bilateral T4aN0 - - R2 254.54/11.36 500.39/13.36
4 Medullary Right lobe T2N1b R: IIA, III, IV, V, VI Y R0 - 641.07/20.78
L: VI
5 Medullary Bilateral T3N1b L: IIA, VI Y R1 93.3/10.62 262.36/18.33
R: VI
6 Medullary Right lobe T2N1b R: III, IV, VI Y R0 206.97/13.37 545.01/18.66
7 Papillary Bilateral T4aN1a R: VI Y R1 124.11/5.9 -
8 Papillary Left lobe T4aN1b L: III, IV, VI Y R1 39.39/4.24 247.87/14.92
9 Medullary Right lobe T3N1b R: III, VI Y R1 83.52/8.59 300.35/16.07
10 Medullary Left lobe T3N1b L: IV, VI Y R1 405.82/22.43 596.87/22.43
R: VI, VII
11 Papillary Bilateral T3N1b R: IV, VI Y R0 51.36/6.02 361.89/17.35
12 Papillary Left lobe T4aN1a L: VI N R1 95.08/8.44 201.39/13.12
Average        194.85/10.8 467.91/17.64
  1. R = right; L = left; R0 = no residual tumor; R1 = microscopic residual tumor; R2 = macroscopic residual tumor; Y = yes; N = No.